Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 143 of 1,261
  1. US 11872355

    Medical device for detecting fluid parameters using fluorescent probes

    Covidien LP · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  2. US 11872200

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  3. US 11873491

    Complement component C5 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  4. US 11872092

    Methods for surgical guidance in breast cancer surgery and lymph node dissection using two or more implantation devices comprising a capsule and a population of ultrasound-switchable fluorophores incorporated in the capsule

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  5. US 11872244

    Thixotropic oxidized cellulose solutions and medical applications thereof

    Covidien LP · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  6. US 11872261

    Lipoprotein targeting protease inhibitors and uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  7. US 11872312

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  8. US 11872203

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  9. US 11872204

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  10. US 11872225

    Pyruvate kinase modulators and use thereof

    Agios Pharmaceuticals, Inc. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  11. US 11873490

    Antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  12. US 11873495

    Compounds and methods for reducing LRRK2 expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  13. US 11873300

    Crystalline forms of CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  14. US 11873350

    Dissolution of oxidized cellulose

    Covidien LP · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  15. US 11873319

    Cyclic di-nucleotide induction of type I interferon

    The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  16. US 11873296

    Solid forms of a dual RAF/MEK inhibitor

    VERASTEM, INC. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  17. EP 4302751

    ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT

    LTS LOHMANN THERAPIE SYSTEME AG [DE] · Granted Jan 10, 2024 · Expires Jan 5, 2044

    granted
  18. EP 4302750

    ORALE DÜNNFILME ENTHALTEND ADRENALIN

    LTS LOHMANN THERAPIE SYSTEME AG [DE] · Granted Jan 10, 2024 · Expires Jan 5, 2044

    granted
  19. US 11866476

    Masked IL-2-Fc fusion polypeptides

    Xilio Development, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  20. US 11866418

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  21. US 11865145

    Compositions and methods for maintaining and restoring a healthy gut barrier

    Finch Therapeutics Holdings LLC · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  22. US 11865126

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Compass Pathfinder Limited · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  23. US 11865157

    Compositions and methods of targeting cancer stem cells

    The Board of Regents of the University of Texas System · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  24. US 11865186

    Gene therapy treatment of atrial fibrillation

    Northwestern University · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.